155 related articles for article (PubMed ID: 31447678)
1. Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis.
Bouscary A; Quessada C; Mosbach A; Callizot N; Spedding M; Loeffler JP; Henriques A
Front Pharmacol; 2019; 10():883. PubMed ID: 31447678
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases.
Bouscary A; Quessada C; René F; Spedding M; Henriques A; Ngo S; Loeffler JP
Eur J Pharmacol; 2020 Oct; 884():173446. PubMed ID: 32739173
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.
Henriques A; Huebecker M; Blasco H; Keime C; Andres CR; Corcia P; Priestman DA; Platt FM; Spedding M; Loeffler JP
Sci Rep; 2017 Jul; 7(1):5235. PubMed ID: 28701774
[TBL] [Abstract][Full Text] [Related]
4. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
5. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase.
Henriques A; Croixmarie V; Priestman DA; Rosenbohm A; Dirrig-Grosch S; D'Ambra E; Huebecker M; Hussain G; Boursier-Neyret C; Echaniz-Laguna A; Ludolph AC; Platt FM; Walther B; Spedding M; Loeffler JP; Gonzalez De Aguilar JL
Hum Mol Genet; 2015 Dec; 24(25):7390-405. PubMed ID: 26483191
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
8. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
9. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.
Dodge JC; Treleaven CM; Pacheco J; Cooper S; Bao C; Abraham M; Cromwell M; Sardi SP; Chuang WL; Sidman RL; Cheng SH; Shihabuddin LS
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8100-5. PubMed ID: 26056266
[TBL] [Abstract][Full Text] [Related]
10. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts.
Sharp PS; Tyreman N; Jones KE; Gordon T
Neurobiol Dis; 2018 May; 113():33-44. PubMed ID: 29409912
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models.
Lee SH; Kim S; Lee N; Lee J; Yu SS; Kim JH; Kim S
Acta Neuropathol Commun; 2019 Jun; 7(1):96. PubMed ID: 31189468
[TBL] [Abstract][Full Text] [Related]
12. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
Rué L; Oeckl P; Timmers M; Lenaerts A; van der Vos J; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Weishaupt JH; Ludolph AC; Otto M; Robberecht W; Lemmens R
Acta Neuropathol Commun; 2019 Jul; 7(1):114. PubMed ID: 31300041
[TBL] [Abstract][Full Text] [Related]
14. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1
Sengupta-Ghosh A; Dominguez SL; Xie L; Barck KH; Jiang Z; Earr T; Imperio J; Phu L; Budayeva HG; Kirkpatrick DS; Cai H; Eastham-Anderson J; Ngu H; Foreman O; Hedehus M; Reichelt M; Hotzel I; Shang Y; Carano RAD; Ayalon G; Easton A
Neurobiol Dis; 2019 Apr; 124():340-352. PubMed ID: 30528255
[TBL] [Abstract][Full Text] [Related]
15. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
16. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury.
Schram S; Chuang D; Schmidt G; Piponov H; Helder C; Kerns J; Gonzalez M; Song F; Loeb JA
Neurobiol Dis; 2019 Apr; 124():469-478. PubMed ID: 30594811
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis.
Maglemose R; Hedegaard A; Lehnhoff J; Dimintiyanova KP; Moldovan M; Grøndahl L; Meehan CF
Exp Neurol; 2017 Jun; 292():154-167. PubMed ID: 28322742
[TBL] [Abstract][Full Text] [Related]
20. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
